Guest Blog: Brain Tumour Research Joins The Neurological Alliance
Sue Farrington Smith, Chief Executive at Brain Tumour Research, writes: We are delighted to be joining The Neurological Alliance, particularly as a member of its Research Interest Group, and look forward to finding opportunities for the neuroscience and brain tumour research communities to work more closely together in tackling the challenges that face people with […]
Building back better – Neurological Alliance priorities for the coming year
We are beginning a new financial year here at the Neurological Alliance and have refreshed our business plans for the next 12 months. It has never been more important for the neurological community to come together to improve treatment, care and support. And we have some exciting plans for the coming year to help do just that.
NHS reorganisation is important, but must not be a distraction from recovery
Our Chief Executive, Georgina Carr, looks at the NHS White Paper in greater detail. Earlier this month, the Government set out its proposals for the most substantial NHS legislation in nearly a decade in its white paper ‘Working together to improve health and social care for all’. Like so many policy wonks in the sector, […]
Forwards into 2021.
Since the start of the year we have been discussing our priorities as a team for the Alliance and setting objectives for 2021. At the beginning of January we welcomed back Katharine McIntosh as our policy manager and said farewell to Judy who worked so hard during 2020 to cover for Katharine and much more […]
The UK Rare Diseases Framework – New hope, or same-old, same-old?
A blog post by our Trustee and CEO of Ataxia UK, Sue Millman In general, most neurological services for people with ataxia haven’t fared well during the Covid-19 pandemic, and it’s the same right across neurology. Most face-to-face outpatients’ clinics have been cancelled, or changed to telephone appointments or virtual consultations – with serious consequences […]